Radiopharm Theranostics Limited’s (Radiopharm or Company) initial public offer made under the prospectus dated 14 October 2021 (Prospectus) and supplementary prospectus dated 28 October 2021 (Supplementary Prospectus) closed successfully on 5 November 2021, with the offer being fully subscribed. Radiopharm has 253,333,557 shares on issue following the Offer.
Quotation of 116,666,984 of Radiopharm’s shares (being those shares not subject to ASX mandatory escrow) is expected to occur at 11.00am (Sydney time) on 25 November 2021 (ASX code: RAD).
For more information, download the attached PDF.
Download this document
